CA2126757A1 - Utilisation de composes trioxolane et diperoxyde en medecine - Google Patents
Utilisation de composes trioxolane et diperoxyde en medecineInfo
- Publication number
- CA2126757A1 CA2126757A1 CA002126757A CA2126757A CA2126757A1 CA 2126757 A1 CA2126757 A1 CA 2126757A1 CA 002126757 A CA002126757 A CA 002126757A CA 2126757 A CA2126757 A CA 2126757A CA 2126757 A1 CA2126757 A1 CA 2126757A1
- Authority
- CA
- Canada
- Prior art keywords
- mammal
- trioxolane
- diperoxide
- unsaturated hydrocarbon
- terpene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81396291A | 1991-12-24 | 1991-12-24 | |
US840,388 | 1992-02-24 | ||
US07/840,388 US5270344A (en) | 1988-06-24 | 1992-02-24 | Method of treating a systemic disorder using trioxolane and diperoxide compounds |
US813,962 | 1997-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2126757A1 true CA2126757A1 (fr) | 1993-07-08 |
Family
ID=27123798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002126757A Abandoned CA2126757A1 (fr) | 1991-12-24 | 1992-12-17 | Utilisation de composes trioxolane et diperoxyde en medecine |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0644716A4 (fr) |
JP (1) | JPH08502018A (fr) |
AU (1) | AU3328293A (fr) |
CA (1) | CA2126757A1 (fr) |
MX (1) | MX9207493A (fr) |
WO (1) | WO1993012654A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN115095A0 (en) * | 1995-02-15 | 1995-03-09 | Butt, Henry Lawrence | Analysis of and compositions and methods for the treatment of disease |
JP3056730B1 (ja) * | 1999-03-31 | 2000-06-26 | 株式会社バイオ技研 | 二形性真菌であるカンジダ属に対する形態転換制御活性機能剤 |
CA2566180A1 (fr) * | 2004-05-10 | 2005-11-24 | Robert F. Hofmann | Utilisation d'une formulation therapeutique oxydative ciblee dans le traitement du cancer |
WO2006002287A1 (fr) * | 2004-06-23 | 2006-01-05 | Hofmann Robert F | Utilisation de preparation therapeutique oxydative ciblee dans un traitement endodontique |
CN101473009A (zh) * | 2006-06-28 | 2009-07-01 | 株式会社Erc科技 | 臭氧化表面活性剂 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1210949A (en) * | 1914-07-30 | 1917-01-02 | Gen Res Lab | Medicinal compound. |
US2083572A (en) * | 1928-04-25 | 1937-06-15 | Susan M Mckee | Process of treating oil |
US2356062A (en) * | 1942-02-03 | 1944-08-15 | Latimer Lab Inc | Therapeutic composition |
US4451480A (en) * | 1982-04-16 | 1984-05-29 | James Howard Brown | Method of treating acne using ozonized materials |
US4591602A (en) * | 1982-04-16 | 1986-05-27 | James H. Brown | Ozonide esters and topical compositions containing same |
US4983637A (en) * | 1988-06-24 | 1991-01-08 | Stephen Herman | Method for treating viral infection of HIV |
US5086076A (en) * | 1988-06-24 | 1992-02-04 | Stephen Herman | Antiviral pharmaceutical compositions comprising a terpene ozonide |
-
1992
- 1992-12-17 AU AU33282/93A patent/AU3328293A/en not_active Abandoned
- 1992-12-17 WO PCT/US1992/010979 patent/WO1993012654A1/fr not_active Application Discontinuation
- 1992-12-17 EP EP93901179A patent/EP0644716A4/en not_active Withdrawn
- 1992-12-17 CA CA002126757A patent/CA2126757A1/fr not_active Abandoned
- 1992-12-17 JP JP5511772A patent/JPH08502018A/ja active Pending
- 1992-12-22 MX MX9207493A patent/MX9207493A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JPH08502018A (ja) | 1996-03-05 |
WO1993012654A1 (fr) | 1993-07-08 |
MX9207493A (es) | 1994-03-31 |
EP0644716A1 (fr) | 1995-03-29 |
EP0644716A4 (en) | 1995-04-19 |
AU3328293A (en) | 1993-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5270344A (en) | Method of treating a systemic disorder using trioxolane and diperoxide compounds | |
US5364879A (en) | Medical uses of trioxolane and diperoxide compounds | |
US5190979A (en) | Ozonides of terpenes and their medical uses | |
US9737498B2 (en) | Method for treating an inflammation or lesion caused by a virus | |
AU627908B2 (en) | Method for treating viral infection | |
US5126376A (en) | Method for treating viral infection using topical administration | |
JPH02124817A (ja) | 局所投与用炎症性疾患治療剤 | |
US5260342A (en) | Method for treating viral infection parenterally | |
US5190977A (en) | Antiviral compositions | |
CA1338083C (fr) | Ozonides de terpenes et leur utilisation medicale | |
US5194451A (en) | Systemic anti-inflammatory treatment | |
US5166219A (en) | Systemic anti-inflammatory treatment | |
US4626530A (en) | Treatment of eye inflammation with biphenamine | |
US5086076A (en) | Antiviral pharmaceutical compositions comprising a terpene ozonide | |
AU645359B2 (en) | Lithium treatment | |
US5071879A (en) | Systemic antiviral treatment | |
CA2126757A1 (fr) | Utilisation de composes trioxolane et diperoxyde en medecine | |
JP3064009B2 (ja) | 抗ウイルス治療におけるc―27ないしc―32脂肪族アルコールの使用 | |
EP1663195B1 (fr) | Procede pour inhiber la croissance de bacteries et de champignons pathogenes et composition microbicide | |
US8492443B2 (en) | Treatment for herpes simplex virus and other infectious diseases | |
US4147785A (en) | Method for the treatment of onchocerciasis | |
JP2023120462A (ja) | 医薬組成物 | |
EA002267B1 (ru) | Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат | |
Carruthers | Dermatological Treatment | |
CA2591352A1 (fr) | Traitement du virus de l'herpes simplex et d'autres maladies infectieuses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |